Belgian pharmaceuticals giant Solvay posts profit rise

July 27, 2012

Belgium's pharmaceuticals giant Solvay announced a better-than-expected 6.0 percent rise in net profit for the second quarter on Friday, sending its shares rising sharply.

Shortly after the opening of trade in Brussels, shares in Solvay showed a 6.94 percent rise to 87.12 euros after the announcement of the results, which show the company on track to do as well in 2012 as the previous year.

Solvay said that despite the in demand in the sector in June, cuts and restructuring would enable it to do as well as in 2011.

The group reported adjusted of 244 million euros from April to June.

Related Stories

Recommended for you

The ethics of tracking athletes' biometric data

January 18, 2017

(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Study shows blood products unaffected by drone trips

December 7, 2016

In what is believed to be the first proof-of-concept study of its kind, Johns Hopkins researchers have determined that large bags of blood products, such as those transfused into patients every day, can maintain temperature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.